153 related articles for article (PubMed ID: 35339615)
1. EWI2 promotes endolysosome-mediated turnover of growth factor receptors and integrins to suppress lung cancer.
Wang J; Wren JD; Ding Y; Chen J; Mittal N; Xu C; Li X; Zeng C; Wang M; Shi J; Zhang YH; Han SJ; Zhang XA
Cancer Lett; 2022 Jun; 536():215641. PubMed ID: 35339615
[TBL] [Abstract][Full Text] [Related]
2. EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancy.
Ding Y; Chen J; Li S; Wren JD; Bajpai AK; Wang J; Tanaka T; Rice HC; Hays FA; Lu L; Zhang XA
Oncogene; 2023 Mar; 42(12):861-868. PubMed ID: 36788350
[TBL] [Abstract][Full Text] [Related]
3. EWI2 prevents EGFR from clustering and endocytosis to reduce tumor cell movement and proliferation.
Fu C; Wang J; Pallikkuth S; Ding Y; Chen J; Wren JD; Yang Y; Wong KK; Kameyama H; Jayaraman M; Munshi A; Tanaka T; Lidke KA; Zhang XA
Cell Mol Life Sci; 2022 Jun; 79(7):389. PubMed ID: 35773608
[TBL] [Abstract][Full Text] [Related]
4. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
[TBL] [Abstract][Full Text] [Related]
5. The tumor suppressor p53 regulates autophagosomal and lysosomal biogenesis in lung cancer cells by targeting transcription factor EB.
Zhang Z; Wang H; Ding Q; Xing Y; Xu D; Xu Z; Zhou T; Qian B; Ji C; Pan X; Zhong A; Ying Z; Zhou C; Shi M
Biomed Pharmacother; 2017 May; 89():1055-1060. PubMed ID: 28292013
[TBL] [Abstract][Full Text] [Related]
6. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.
Lee KY; Shueng PW; Chou CM; Lin BX; Lin MH; Kuo DY; Tsai IL; Wu SM; Lin CW
Cancer Sci; 2020 May; 111(5):1652-1662. PubMed ID: 32133706
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells.
Kinehara Y; Nagatomo I; Koyama S; Ito D; Nojima S; Kurebayashi R; Nakanishi Y; Suga Y; Nishijima-Futami Y; Osa A; Nakatani T; Kato Y; Nishide M; Hayama Y; Higashiguchi M; Morimura O; Miyake K; Kang S; Minami T; Hirata H; Iwahori K; Takimoto T; Takamatsu H; Takeda Y; Hosen N; Hoshino S; Shintani Y; Okumura M; Kumagai T; Nishino K; Imamura F; Nakatsuka SI; Kijima T; Kida H; Kumanogoh A
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568033
[TBL] [Abstract][Full Text] [Related]
8. Differential functions of phospholipid binding and palmitoylation of tumour suppressor EWI2/PGRL.
He B; Zhang YH; Richardson MM; Zhang JS; Rubinstein E; Zhang XA
Biochem J; 2011 Aug; 437(3):399-411. PubMed ID: 21609323
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.
Davison E; Kirby I; Whitehouse J; Hart I; Marshall JF; Santis G
J Gene Med; 2001; 3(6):550-9. PubMed ID: 11778901
[TBL] [Abstract][Full Text] [Related]
10. DRAM1 plays a tumor suppressor role in NSCLC cells by promoting lysosomal degradation of EGFR.
Geng J; Zhang R; Yuan X; Xu H; Zhu Z; Wang X; Wang Y; Xu G; Guo W; Wu J; Qin ZH
Cell Death Dis; 2020 Sep; 11(9):768. PubMed ID: 32943616
[TBL] [Abstract][Full Text] [Related]
11. SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing.
Zhu S; Chen W; Wang J; Qi L; Pan H; Feng Z; Tian D
Theranostics; 2021; 11(7):3359-3375. PubMed ID: 33537092
[No Abstract] [Full Text] [Related]
12. MIIP accelerates epidermal growth factor receptor protein turnover and attenuates proliferation in non-small cell lung cancer.
Wen J; Fu J; Ling Y; Zhang W
Oncotarget; 2016 Feb; 7(8):9118-34. PubMed ID: 26824318
[TBL] [Abstract][Full Text] [Related]
13. SOX30 is a key regulator of desmosomal gene suppressing tumor growth and metastasis in lung adenocarcinoma.
Hao X; Han F; Ma B; Zhang N; Chen H; Jiang X; Yin L; Liu W; Ao L; Cao J; Liu J
J Exp Clin Cancer Res; 2018 May; 37(1):111. PubMed ID: 29855376
[TBL] [Abstract][Full Text] [Related]
14. Cucurbitacin B Induces the Lysosomal Degradation of EGFR and Suppresses the CIP2A/PP2A/Akt Signaling Axis in Gefitinib-Resistant Non-Small Cell Lung Cancer.
Liu P; Xiang Y; Liu X; Zhang T; Yang R; Chen S; Xu L; Yu Q; Zhao H; Zhang L; Liu Y; Si Y
Molecules; 2019 Feb; 24(3):. PubMed ID: 30759826
[TBL] [Abstract][Full Text] [Related]
15. Expression profiling of integrins in lung cancer cells.
Guo L; Zhang F; Cai Y; Liu T
Pathol Res Pract; 2009; 205(12):847-53. PubMed ID: 19674850
[TBL] [Abstract][Full Text] [Related]
16. Beta 1 integrin expression on human small cell lung cancer cells.
Feldman LE; Shin KC; Natale RB; Todd RF
Cancer Res; 1991 Feb; 51(4):1065-70. PubMed ID: 1705164
[TBL] [Abstract][Full Text] [Related]
17. Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties.
Si J; Ma Y; Bi JW; Xiong Y; Lv C; Li S; Wu N; Yang Y
J Exp Clin Cancer Res; 2019 Dec; 38(1):481. PubMed ID: 31801598
[TBL] [Abstract][Full Text] [Related]
18. Low-Dose Nicotine Activates EGFR Signaling via α5-nAChR and Promotes Lung Adenocarcinoma Progression.
Wang ML; Hsu YF; Liu CH; Kuo YL; Chen YC; Yeh YC; Ho HL; Wu YC; Chou TY; Wu CW
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957649
[TBL] [Abstract][Full Text] [Related]
19. pVHL promotes lysosomal degradation of YAP in lung adenocarcinoma.
Hu L; Wu H; Jiang T; Kuang M; Liu B; Guo X; He D; Chen M; Gu J; Gu J; Chang L; Feng M; Ruan Y
Cell Signal; 2021 Jul; 83():110002. PubMed ID: 33823241
[TBL] [Abstract][Full Text] [Related]
20. Cyano Enone-Bearing Triterpenoid Soloxolone Methyl Inhibits Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cells In Vitro and Metastasis of Murine Melanoma In Vivo.
Markov AV; Odarenko KV; Sen'kova AV; Salomatina OV; Salakhutdinov NF; Zenkova MA
Molecules; 2020 Dec; 25(24):. PubMed ID: 33327637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]